435 related articles for article (PubMed ID: 16129781)
21. Transforming growth factor-beta1 decreases melanin synthesis via delayed extracellular signal-regulated kinase activation.
Kim DS; Park SH; Park KC
Int J Biochem Cell Biol; 2004 Aug; 36(8):1482-91. PubMed ID: 15147727
[TBL] [Abstract][Full Text] [Related]
22. Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas.
Giuliano S; Cheli Y; Ohanna M; Bonet C; Beuret L; Bille K; Loubat A; Hofman V; Hofman P; Ponzio G; Bahadoran P; Ballotti R; Bertolotto C
Cancer Res; 2010 May; 70(9):3813-22. PubMed ID: 20388797
[TBL] [Abstract][Full Text] [Related]
23. Genomic analysis of the Microphthalmia locus and identification of the MITF-J/Mitf-J isoform.
Hershey CL; Fisher DE
Gene; 2005 Feb; 347(1):73-82. PubMed ID: 15715979
[TBL] [Abstract][Full Text] [Related]
24. Lipocalin-type prostaglandin D synthase as a melanocyte marker regulated by MITF.
Takeda K; Yokoyama S; Aburatani H; Masuda T; Han F; Yoshizawa M; Yamaki N; Yamamoto H; Eguchi N; Urade Y; Shibahara S
Biochem Biophys Res Commun; 2006 Jan; 339(4):1098-106. PubMed ID: 16337607
[TBL] [Abstract][Full Text] [Related]
25. Induction of microphthalmia transcription factor (Mitf) by forskolin and stimulation of melanin release in UISO-Mel-6 cells.
Lekmine F; Salti GI
J Surg Res; 2008 Sep; 149(1):27-30. PubMed ID: 18028952
[TBL] [Abstract][Full Text] [Related]
26. A single UVB exposure increases the expression of functional KIT in human melanocytes by up-regulating MITF expression through the phosphorylation of p38/CREB.
Mizutani Y; Hayashi N; Kawashima M; Imokawa G
Arch Dermatol Res; 2010 May; 302(4):283-94. PubMed ID: 19937254
[TBL] [Abstract][Full Text] [Related]
27. The transcription factor onecut-2 controls the microphthalmia-associated transcription factor gene.
Jacquemin P; Lannoy VJ; O'Sullivan J; Read A; Lemaigre FP; Rousseau GG
Biochem Biophys Res Commun; 2001 Aug; 285(5):1200-5. PubMed ID: 11478782
[TBL] [Abstract][Full Text] [Related]
28. B-RAF: A contributor to the melanoma phenotype.
Heath EM; Kaufman KL; Christopherson RI
Int J Biochem Cell Biol; 2011 Jan; 43(1):29-32. PubMed ID: 20883818
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic B-Raf(V600E) induces spindle abnormalities, supernumerary centrosomes, and aneuploidy in human melanocytic cells.
Cui Y; Borysova MK; Johnson JO; Guadagno TM
Cancer Res; 2010 Jan; 70(2):675-84. PubMed ID: 20068179
[TBL] [Abstract][Full Text] [Related]
30. Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro.
Cook AL; Smith AG; Smit DJ; Leonard JH; Sturm RA
Exp Cell Res; 2005 Aug; 308(1):222-35. PubMed ID: 15896776
[TBL] [Abstract][Full Text] [Related]
31. Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage.
Goding CR
Genes Dev; 2000 Jul; 14(14):1712-28. PubMed ID: 10898786
[No Abstract] [Full Text] [Related]
32. Mitf expression is sufficient to direct differentiation of medaka blastula derived stem cells to melanocytes.
Béjar J; Hong Y; Schartl M
Development; 2003 Dec; 130(26):6545-53. PubMed ID: 14660543
[TBL] [Abstract][Full Text] [Related]
33. B-Raf and C-Raf are required for melanocyte stem cell self-maintenance.
Valluet A; Druillennec S; Barbotin C; Dorard C; Monsoro-Burq AH; Larcher M; Pouponnot C; Baccarini M; Larue L; Eychène A
Cell Rep; 2012 Oct; 2(4):774-80. PubMed ID: 23022482
[TBL] [Abstract][Full Text] [Related]
34. B-RAF is a therapeutic target in melanoma.
Karasarides M; Chiloeches A; Hayward R; Niculescu-Duvaz D; Scanlon I; Friedlos F; Ogilvie L; Hedley D; Martin J; Marshall CJ; Springer CJ; Marais R
Oncogene; 2004 Aug; 23(37):6292-8. PubMed ID: 15208680
[TBL] [Abstract][Full Text] [Related]
35. In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling.
Dumaz N; Hayward R; Martin J; Ogilvie L; Hedley D; Curtin JA; Bastian BC; Springer C; Marais R
Cancer Res; 2006 Oct; 66(19):9483-91. PubMed ID: 17018604
[TBL] [Abstract][Full Text] [Related]
36. MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.
Du J; Miller AJ; Widlund HR; Horstmann MA; Ramaswamy S; Fisher DE
Am J Pathol; 2003 Jul; 163(1):333-43. PubMed ID: 12819038
[TBL] [Abstract][Full Text] [Related]
37. Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
Goodall J; Carreira S; Denat L; Kobi D; Davidson I; Nuciforo P; Sturm RA; Larue L; Goding CR
Cancer Res; 2008 Oct; 68(19):7788-94. PubMed ID: 18829533
[TBL] [Abstract][Full Text] [Related]
38. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
[TBL] [Abstract][Full Text] [Related]
39. Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway.
Gaggioli C; Robert G; Bertolotto C; Bailet O; Abbe P; Spadafora A; Bahadoran P; Ortonne JP; Baron V; Ballotti R; Tartare-Deckert S
J Invest Dermatol; 2007 Feb; 127(2):400-10. PubMed ID: 16960555
[TBL] [Abstract][Full Text] [Related]
40. Partially purified Curcuma longa inhibits alpha-melanocyte-stimulating hormone-stimulated melanogenesis through extracellular signal-regulated kinase or Akt activation-mediated signalling in B16F10 cells.
Jang JY; Lee JH; Jeong SY; Chung KT; Choi YH; Choi BT
Exp Dermatol; 2009 Aug; 18(8):689-94. PubMed ID: 19469902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
